BackgroundTRIUMPH (Trans Research-Informed communities United in Mobilization for the Prevention of HIV) was a community-led, transgender-specific pre-exposure prophylaxis (PrEP) demonstration project at 2 community-based clinical sites in California. TRIUMPH used peer health education, community mobilization, and clinical integration of PrEP with hormone therapy to promote PrEP knowledge and acceptability. The goal of this study was to evaluate PrEP uptake, retention, and adherence among TRIUMPH participants and examine site-based differences.MethodsEligible participants were adult transgender and gender diverse people interested in PrEP. Participants were seen at baseline and at 1, 3, 6, 9, and 12 months for PrEP provision, clinical visit...
Little information is known about the cisgender women who seek and initiate pre-exposure prophylaxis...
Lessons were learned with trans women who participated (as volunteers and investigators) in trials o...
A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabr...
BackgroundTRIUMPH (Trans Research-Informed communities United in Mobilization for the Prevention of ...
Black and Latinx transgender women in the United States (U.S.) are at disproportionately high risk f...
Transgender women face a serious risk of HIV infection. Despite this, there is limited knowledge and...
BackgroundPrior to implementing a pre-exposure prophylaxis (PrEP) demonstration study, we sought to ...
Background: An international randomized clinical trial (RCT) on pre-exposure prophylaxis (PrEP) as a...
While transgender and gender non-binary (trans/nb) individuals are disproportionately affected by HI...
Abstract Background An international randomized clinical trial (RCT) on pre-exposure prophylaxis (Pr...
Background Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy, but it is ...
Black and Hispanic/Latinx transgender women in the United States (U.S.) are disproportionately affec...
BackgroundHIV testing and pre-exposure prophylaxis (PrEP) are effective HIV prevention strategies of...
Abstract Background Prior to implementing a pre-expos...
Safe and effective HIV prevention strategies are needed for transwomen. Transwomen in the US have a ...
Little information is known about the cisgender women who seek and initiate pre-exposure prophylaxis...
Lessons were learned with trans women who participated (as volunteers and investigators) in trials o...
A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabr...
BackgroundTRIUMPH (Trans Research-Informed communities United in Mobilization for the Prevention of ...
Black and Latinx transgender women in the United States (U.S.) are at disproportionately high risk f...
Transgender women face a serious risk of HIV infection. Despite this, there is limited knowledge and...
BackgroundPrior to implementing a pre-exposure prophylaxis (PrEP) demonstration study, we sought to ...
Background: An international randomized clinical trial (RCT) on pre-exposure prophylaxis (PrEP) as a...
While transgender and gender non-binary (trans/nb) individuals are disproportionately affected by HI...
Abstract Background An international randomized clinical trial (RCT) on pre-exposure prophylaxis (Pr...
Background Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy, but it is ...
Black and Hispanic/Latinx transgender women in the United States (U.S.) are disproportionately affec...
BackgroundHIV testing and pre-exposure prophylaxis (PrEP) are effective HIV prevention strategies of...
Abstract Background Prior to implementing a pre-expos...
Safe and effective HIV prevention strategies are needed for transwomen. Transwomen in the US have a ...
Little information is known about the cisgender women who seek and initiate pre-exposure prophylaxis...
Lessons were learned with trans women who participated (as volunteers and investigators) in trials o...
A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabr...